Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.
SeaArt is an AI platform for generating and editing images, videos, audio, and AI character chats through text and image prompts.
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.
Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.
PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
Chromai offers high-performance intelligent liquid chromatography and medical diagnostic solutions.
Bluesail Surgical is a surgical device company that specializes in the development of surgical instruments for cardiovascular treatments.
Hyperway Pharm IS A Pharmaceutical research and development production enterprise
Moyang Biotechnology develops and sells nano to micro biomedical materials and implantable products.
Leaf Biotech is a manufacturing company that researches, develops, and markets biological materials and biomedicine.
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.
uBriGene is driven by the advancement of gene and cell therapy technologies through research and development.
Chuanxin Biotech is an RNA drug research and development service provider.
MobiDrop is a precision diagnosis and life science research service provider.
Argo Biopharma is an RNAi drug research and development platform focused on siRNA drug development.
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
MindRank is a clinical stage AI-powered drug discovery company.
Singlomics uses single-cell sequencing technology for antibody drug discovery.
Innolake Biopharm clinical-stage biotech company with a focus on oncology and autoimmune disease areas.
Beeplus Co-working Space is a co-working space operator.
LIBAOTE is a manufacturing company that focuses on supplying fresh frozen meat to restaurants and shops.
Reliable Med is a medical device developer.
H.Extract is engaged in development, production and sales of the natural plant extracts.
Huojianpai is a commercial aerospace company providing earth-moon space economy and future-oriented deep space exploration.
Huagai Capital has invested in 75 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Huagai Capital's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Biopharma. The firm invests across 29 different industry categories.
Among tracked funding rounds, JOINN Biologics received $150.0M in a Series B round. Huagai Capital's total known invested capital is $2.0B.
Huagai Capital's average investment size is $40.6M across its portfolio of 75 companies.
Recent Huagai Capital portfolio additions include JOINN Biologics, SeaArt, PAQ Therapeutics, Carmine Therapeutics, PrinoPharma. These companies were founded in 2020 or later.